Overview
Chronic kidney disease (CKD) is a sustained decline in kidney function or evidence of kidney damage lasting three months or longer. The kidneys filter waste and excess fluid, balance electrolytes and blood pressure, and support red blood cell and bone health, so gradual changes can ripple across many systems. CKD is common worldwide and becomes more prevalent with age; the most frequent contributors are long-standing high blood pressure and diabetes. Many people feel well in earlier stages and first learn of it through routine blood or urine tests. Viewed through a full-body optimization lens, kidney function is less an isolated organ readout than a mirror of cardiovascular and metabolic health, which is why it is often considered alongside blood pressure, glucose and lipid patterns.
The Underlying Biology
Kidney function is commonly summarized by the estimated glomerular filtration rate (eGFR), calculated from serum creatinine and sometimes cystatin C, together with urine albumin measured as the albumin-to-creatinine ratio (UACR). CKD is staged by combining these, since filtering capacity and protein leakage carry independent information. Each kidney holds roughly a million nephrons whose glomeruli filter plasma; when nephrons are lost or stressed, remaining ones compensate through hyperfiltration, a state that can accelerate further injury over time. Central mechanisms studied include activation of the renin-angiotensin-aldosterone system (RAAS), elevated intraglomerular pressure, podocyte and endothelial injury, oxidative stress, and progressive interstitial fibrosis. In diabetes, hyperglycemia drives glomerular changes; in hypertension, sustained pressure strains the microvasculature. As function declines, downstream markers shift—phosphate, parathyroid hormone, potassium, bicarbonate and hemoglobin—reflecting the kidney's roles in mineral, acid-base and red-cell regulation. Research consistently links reduced eGFR and higher albuminuria with cardiovascular risk, and ongoing work continues to explore how blood pressure, glucose control, body composition and nutrition modulate these pathways—underscoring why CKD is examined as a cardiometabolic phenomenon rather than a purely renal one.
What the Research Explores
- Explores how blood pressure and RAAS activity relate to intraglomerular pressure and kidney strain
- Investigates whether glucose and metabolic control are associated with the trajectory of kidney markers
- Examines eGFR and urine albumin (UACR) together as a combined picture of filtration and damage
- Studies the tight two-way link between kidney function and cardiovascular health over time
- Reviews how nutrition, hydration, body composition and activity may influence kidney-related markers
- Considers the role of kidney function in mineral, acid-base and red-cell balance for healthy aging
Who May Find This Relevant
- People exploring what a reduced eGFR or elevated urine albumin on labs may reflect
- Individuals with high blood pressure, insulin resistance or diabetes seeking broader context
- Those with a family history of kidney or cardiometabolic conditions wanting a fuller picture
- Anyone focused on longevity who wants physician-guided insight into kidney and cardiovascular health
Important Considerations
This overview is educational only and is not a diagnosis, treatment plan, or a substitute for medical evaluation. Chronic kidney disease must be assessed and managed together with your own physician, who can interpret your eGFR, urine tests, history and medications. Any metabolic or cardiovascular optimization support is considered one-on-one with Dr. Rob, and individual situations vary considerably.
